Research Article
Prevalence and Clinical Characteristics of Probable REM Behavior Disorder in Thai Parkinson’s Disease Patients
| Variable | (N = 68) |
| Male gender: n (%) | 38 (55.9%) | Age of RBD onset (year: mean ± SD) | 55.9 ± 8.94 | Duration from RBD onset to PD diagnosis (year: median, range) | 5 (0–15) | RBD notice after PD was diagnosed: n (%) | 10 (14.7%) | Dream enactment behavior | | Noninjurious RBD | | Vocalization only: n (%) | 39 (57.3%) | Vocalization with noninjurious limb movement: n (%) | 17 (25.0%) | Injurious RBD | | Falling out of bed: n (%) | 8 (11.7%) | Injury to bed partner: n (%) | 4 (5.8%) | The most rememberable dream content | | Human- or ghost-related violence: n (%) | 35 (51.5%) | Animal-related violence: n (%) | 8 (11.8%) | Accident involving self, such as drowning, falling: n (%) | 4 (5.9%) | Nonviolent acts, such as working, traveling: n (%) | 9 (13.2%) | Cannot remember: n (%) | 12 (17.6%) | Details of phenomenon | | Duration of each episode (2–10 min): n (%) | 47 (69.1%) | Times per night (once per night): n (%) | 58 (85.3%) | Period of night (late night): n (%) | 63 (92.6%) | Dystonic feature (number): n (%) | 52 (76.5%) | Stereotype (number): n (%) | 43 (63.3%) | Recall (vividly): n (%) | 46 (67.6%) | Behavior related to dream content: n (%) | 12 (17%) | Medication | | Clonazepam: n (%) | 45 (69.2%) | SSRI: n (%) | 2 (0.03%) | Melatonin: n (%) | 8 (11.7%) | Dopamine agonist: n (%) | 16 (23.5%) | Cholinesterase inhibitor: n (%) | 5 (7.3%) |
|
|